Metropolis Healthcare Limited, a pathology laboratory chain, has announced the acquisition of Delhi NCR-based Core Diagnostics, a company specialising in advanced cancer testing for Rs 246.8 crores.

Diagnostic chain Metropolis Healthcare on Monday said it will acquire Core Diagnostics for Rs 247 crore. The company's board has approved the acquisition of 100 per cent stake in Core Diagnostics from ...

SRM Institute of Science and Technology (SRMIST) has signed a Memorandum of Understanding (MoU) with CORE Diagnostics, a global leader in cancer diagnostics and genomic testing. With cancer care ...

Abbott ABT, a global leader in healthcare solutions, recently achieved a significant milestone with the FDA approval of its cutting-edge Alinity h-series hematology system. This approval is poised to ...